ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,791, issued on Feb. 17, was assigned to Gasherbrum Bio Inc. (South San Francisco, Calif.).
"Heterocyclic GLP-1 agonists" was invented by Qinghua Meng (Shanghai), Andrew Jennings (Shanghai), Hui Lei (Shanghai) and Xichen Lin (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same."
The patent was filed on March 18, 2025, under Application No. 19/083,274.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect...